다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Allergy, asthma & immunology research, v.10 no.6, 2018년, pp.686 - 697
Kim, Chang-Keun (Asthma & Allergy Center, Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul, Korea .) , Callaway, Zak (Asthma & Allergy Center, Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul, Korea .) , Park, Jin-Sung (Asthma & Allergy Center, Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul, Korea .) , Nishimori, Hisashi (Department of Pediatrics, Mie Prefectural General Medical Center, Tsu, Japan .) , Ogino, Tikatoshi (Niko Niko Child Clinic, Tsu, Japan .) , Nagao, Mizuho (Institute for Clinical Research, Mie National Hospital, Tsu, Japan .) , Fujisawa, Takao (Institute for Clinical Research, Mie National Hospital, Tsu, Japan .)
AI-Helper
PurposeSeveral markers for eosinophilic inflammation have been proposed to predict response to asthma treatment. However, definitive criteria for treatment decisions have not yet been established. We investigate a potentially useful relatively non-invasive biomarker, eosinophil-derived neurotoxin (E...
1 Liu AH Covar RA Spahn JD Leung DY Childhood asthma Kliegman RM Behrman RE Jenson HB Stanton B Nelson textbook of pediatrics 18th ed Philadelphia (PA) Saunders 2007 953 970
2 Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention [Internet] place unknown Global Initiative for Asthma 2017 2017 Aug 18 Available from: http://www.ginasthma.org
3 Obase Y Shimoda T Tomari SY Mitsuta K Kawano T Matsuse H Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients Chest 2002 121 143 150 11796443
4 Zeiger RS Szefler SJ Phillips BR Schatz M Martinez FD Chinchilli VM Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma J Allergy Clin Immunol 2006 117 45 52 16387583
5 Szefler SJ Phillips BR Martinez FD Chinchilli VM Lemanske RF Jr Strunk RC Characterization of within-subject responses to fluticasone and montelukast in childhood asthma J Allergy Clin Immunol 2005 115 233 242 15696076
6 Lemanske RF Jr Mauger DT Sorkness CA Jackson DJ Boehmer SJ Martinez FD Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids N Engl J Med 2010 362 975 985 20197425
7 Sporik R Holgate ST Platts-Mills TA Cogswell JJ Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study N Engl J Med 1990 323 502 507 2377175
8 Green RH Brightling CE McKenna S Hargadon B Parker D Bradding P Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 2002 360 1715 1721 12480423
9 Szefler SJ Mitchell H Sorkness CA Gergen PJ O'Connor GT Morgan WJ Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial Lancet 2008 372 1065 1072 18805335
10 Koh YY Kang H Kim CK Ratio of serum eosinophil cationic protein/blood eosinophil counts in children with asthma: comparison between acute exacerbation and clinical remission Allergy Asthma Proc 2003 24 269 274 12974194
11 Yoshihara S Yamada Y Abe T Lindén A Arisaka O Association of epithelial damage and signs of neutrophil mobilization in the airways during acute exacerbations of paediatric asthma Clin Exp Immunol 2006 144 212 216 16634793
12 Kim CK Callaway Z Fletcher R Koh YY Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity J Asthma 2010 47 568 573 20560830
13 Kim CK Seo JK Ban SH Fujisawa T Kim DW Callaway Z Eosinophil-derived neurotoxin levels at 3 months post-respiratory syncytial virus bronchiolitis are a predictive biomarker of recurrent wheezing Biomarkers 2013 18 230 235 23557131
14 Hamasaki Y Kohno Y Ebisawa M Kondo N Nishima S Nishimuta T Japanese guideline for childhood asthma 2014 Allergol Int 2014 63 335 356
15 Matsson P Hamilton RG Esch RE Analytical performance characteristics and clinical utility of immunological assays for human immunoglobulin E (IgE) antibodies and defined allergen specificities: approved guidelines 2nd ed Wayne (PA) Clinical and Laboratory Standards Institute 2008
16 Motojima S Akutsu I Fukuda T Makino S Takatsu K Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma Allergy 1993 48 98 106 8109721
17 Venge P Monitoring the allergic inflammation Allergy 2004 59 26 32 14674929
18 Abu-Ghazaleh RI Dunnette SL Loegering DA Checked JL Kita H Thomas LL Eosinophil granule proteins in peripheral blood granulocytes J Leukoc Biol 1992 52 611 618 1464733
19 Morioka J Kurosawa M Inamura H Nakagami R Mizushima Y Omura Y Increased END/EPX in ongoing asthma Allergy 2000 55 1203 1204 11117285
20 Kim CK Choi J Kim HB Callaway Z Shin BM Kim JT A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation J Pediatr 2010 156 749 754 20171653
21 Hofhuis W van der Wiel EC Nieuwhof EM Hop WC Affourtit MJ Smit FJ Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants Am J Respir Crit Care Med 2005 171 328 333 15531753
22 Chauhan BF Ducharme FM Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children Cochrane Database Syst Rev 2012 5 CD002314
23 Taniuchi S Chihara J Kojima T Yamamoto A Sasai M Kobayashi Y Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein J Dermatol Sci 2001 26 79 82 11323224
24 Sedgwick JB Vrtis RF Jansen KJ Kita H Bartemes K Busse WW Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin J Allergy Clin Immunol 2004 114 568 574 15356558
25 Garofalo R Kimpen JL Welliver RC Ogra PL Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection J Pediatr 1992 120 28 32 1731020
26 Moqbel R Lace P Adamko DJ Odemuyiwa SO Biology of eosinophils Adkinson NF Jr Bochner BS Busse WW Holgate ST Lemanske RF Jr Simons FE Allergy: principles & practice St. Louis (MO) Mosby 2008 295 310
27 Kim CK Callaway Z Gern JE Viral infections and associated factors that promote acute exacerbations of asthma Allergy Asthma Immunol Res 2018 10 12 17 29178673
28 Petsky HL Kynaston JA Turner C Li AM Cates CJ Lasserson TJ Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults Cochrane Database Syst Rev 2007 2 CD005603
29 Chlumský J Striz I Terl M Vondracek J Strategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthma J Int Med Res 2006 34 129 139 16749408
30 Jayaram L Pizzichini MM Cook RJ Boulet LP Lemière C Pizzichini E Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Eur Respir J 2006 27 483 494 16507847
31 Adamko DJ Odemuyiwa SO Vethanayagam D Moqbel R The rise of the phoenix: the expanding role of the eosinophil in health and disease Allergy 2005 60 13 22 15575925
32 Kim KW Lee KE Kim ES Song TW Sohn MH Kim KE Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma Lung 2007 185 97 103 17393238
33 Kim CK Callaway Z Park JS Kwon E Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma Allergol Int 2017 66 70 74 27329145
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.